Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MINER: Resveratrol for Gulf War Illness
NCT03665740Phase 2Unknown
- Sponsor
- VISN 17 Center of Excellence for Research on Returning War Veterans
- Start
- Aug 2018
- Primary completion
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of resveratrol in Gulf War syndrome (GWS), sponsored by VISN 17 Center of Excellence for Research on Returning War Veterans. Status: unknown.
02
Drugs
resveratrol
03
Conditions
Gulf War syndrome (GWS)
Beyond the preview
Go deeper on NCT03665740.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03665740.